Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 137

Results For "IFF"

1815 News Found

Glamyo Health records ARR of US $ 8 million last fiscal
Startup | April 25, 2022

Glamyo Health records ARR of US $ 8 million last fiscal

It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care


Twenty eight companies commit to Rs 6000 crore at Global Ayush meet
News | April 23, 2022

Twenty eight companies commit to Rs 6000 crore at Global Ayush meet

The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said


Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK
Biotech | April 23, 2022

Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK

The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


Ayush Master Chef winners announced
News | April 22, 2022

Ayush Master Chef winners announced

Within a fortnight, over 200 contestants sent their entries for the competition, and 30 names were shortlisted after screening entries under different categories


WHO recommends Paxlovid for Covid-19 therapy
News | April 22, 2022

WHO recommends Paxlovid for Covid-19 therapy

This recommendation is based on new data from two randomized controlled trials involving 3078 patients


USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
Biotech | April 22, 2022

USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic


Qvella FAST System and FAST-PBC get CE marked and USFDA listed
Biotech | April 22, 2022

Qvella FAST System and FAST-PBC get CE marked and USFDA listed

With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods


Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
Biotech | April 21, 2022

Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results

Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both


Celogics license in NEXEL's Cardiosight-S for global distribution
Biotech | April 20, 2022

Celogics license in NEXEL's Cardiosight-S for global distribution

The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development